BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang GY, Zhang XY, Wang CJ, Guan YF. Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies. World J Gastroenterol 2023; 29(1): 75-95 [PMID: 36683713 DOI: 10.3748/wjg.v29.i1.75]
URL: https://www.wjgnet.com/1007-9327/full/v29/i1/75.htm
Number Citing Articles
1
Yongyi Liang, Shaojun Qiu, Youwen Zou, Lianxiang Luo. Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapiesPhytomedicine 2024; 122: 155134 doi: 10.1016/j.phymed.2023.155134
2
Zhichao Lang, Suhui Yu, Yuhang Hu, Qiqi Tao, Jingnan Zhang, Haoyue Wang, Lei Zheng, Zhixian Yu, Jianjian Zheng. Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11Phytomedicine 2023; 118: 154950 doi: 10.1016/j.phymed.2023.154950
3
Lucia Longhitano, Alfio Distefano, Nicolò Musso, Paolo Bonacci, Laura Orlando, Sebastiano Giallongo, Daniele Tibullo, Simona Denaro, Giuseppe Lazzarino, Jessica Ferrigno, Anna Nicolosi, Amer M. Alanazi, Federico Salomone, Emanuela Tropea, Ignazio Alberto Barbagallo, Vincenzo Bramanti, Giovanni Li Volti, Giacomo Lazzarino, Daniele Torella, Angela Maria Amorini. (+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver diseaseJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-04880-x